ANTI-TUMOR IMMUNITY AND TUMOR ANTI-IMMUNITY IN A MATHEMATICAL MODEL OF TUMOR IMMUNOTHERAPY
From MaRDI portal
Publication:5468606
DOI10.1142/S0218339006001702zbMath1099.92033OpenAlexW2038689128WikidataQ113777227 ScholiaQ113777227MaRDI QIDQ5468606
Jacek Waniewski, Petar Zhivkov, Urszula Fory's
Publication date: 10 May 2006
Published in: Journal of Biological Systems (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1142/s0218339006001702
Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60) Stability theory for ordinary differential equations (34D99)
Related Items
Dynamic aspects of tumour–immune system interaction under a periodic immunotherapy, Optimal Control of Cancer Treatments: Mathematical Models for the Tumor Microenvironment, Dynamics of a tumor-immune model considering targeted chemotherapy, Complicated dynamics of tumor-immune system interaction model with distributed time delay, The nature of Hopf bifurcation for the Gompertz model with delays, Dynamics of tumor-\( \text{CD}4^+\)-cytokine-host cells interactions with treatments, Bang-bang optimal controls for a mathematical model of chemo- and immunotherapy in cancer, An immune system-tumour interactions model with discrete time delay: model analysis and validation, Interactions between the immune system and cancer: A brief review of non-spatial mathematical models, Influence of distributed delays on the dynamics of a generalized immune system cancerous cells interactions model, About a generalized model of lymphoma, Tractable Model of Malignant Gliomas Immunotherapy with Discrete Time Delays, A dynamical model of tumour immunotherapy, A study of tumour growth based on stoichiometric principles: a continuous model and its discrete analogue, Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors, Cost-effectiveness analysis of optimal strategy for tumor treatment, Metamodeling tumor-immune system interaction, tumor evasion and immunotherapy, Qualitative behavior of systems of tumor-CD4+-cytokine interactions with treatments, Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line, Dynamics and control of a mathematical model for metronomic chemotherapy
Cites Work
